President Trump today met with pharmaceutical industry lobbyists to inform them of his new plan that involves "lowering taxes" and "getting rid of regulations."
Reporters seemed confused about how exactly Trump would legislate lower drug prices. Some felt that he was backing off an earlier pledge to allow Medicare to negotiate drug prices; others weren't so sure. As Sarah Karlin-Smith from Politico put it: "It was a very confusing statement, in an already very confusing speech…"
I did not interpret Trump's remarks as backing off pledge to legislate lower drug prices i.e. Medicare negotiation. Did I mis-hear? https://t.co/UsOpwFGZqU— Adam Feuerstein (@adamfeuerstein) January 31, 2017